Upgrade to SI Premium - Free Trial

Goldman Sachs Not Convinced Clorox (CLX) Q2 'Beat' was Real

February 5, 2013 11:05 AM
Goldman Sachs bumped estimates and its price target on Clorox (NYSE: CLX) higher following Q2 results which easily beat the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles